I-Bridge Capital Teams Up With BioLineRx To Launch Healthcare Incubator

I-Bridge Capital, a healthcare-focused venture capital firm and incubator founded by an ex-partner of Kleiner Perkins Caufield & Byers (KPCB), has established a joint venture with Israeli drug company BioLineRx Ltd. to incubate innovative healthcare start-ups.

The joint venture, named iPharma, will seek to develop innovative clinical and pre-clinical therapeutic projects originating primarily in Israel to serve the Chinese and global healthcare markets.

Each partner is to provide seed capital of US$1 million to the venture.

"The market in China is large and fast-growing, but it lacks innovative therapeutic assets and capabilities which address the increasing demands of our rapidly aging population," says Dr. Jimmy Wei, managing partner and founder of I-Bridge Capital, previously at KPCB for four years, in Continue Reading the Entire Article Here >>

This news article comes via , who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of China Money Network

You May Also Like